This article has been updated from a previous version to include additional information about the saliva collection device specified in the EUA summary.
NEW YORK – The US Food and Drug Administration on Friday granted Emergency Use Authorization to the Rutgers Clinical Genomics Laboratory for a SARS-CoV-2 test originally developed by Thermo Fisher Scientific that is modified for use on additional specimen types, including saliva, as well as with alternative nucleic acid extraction and amplification systems.